KZR — Kezar Life Sciences Balance Sheet
0.000.00%
Last trade - 00:00
- $62.81m
- -$128.50m
- $7.00m
- 18
- 34
- 32
- 18
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 78.2 | 140 | 208 | 277 | 201 |
Net Total Receivables | — | 0.766 | 0.07 | — | 2.29 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 81.1 | 145 | 212 | 286 | 207 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8.1 | 6.75 | 6 | 13.2 | 8.69 |
Other Long Term Assets | |||||
Total Assets | 89.5 | 152 | 218 | 300 | 221 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6 | 6.44 | 8.21 | 11 | 17.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11.5 | 10.9 | 21.1 | 29.7 | 33.7 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 78 | 141 | 197 | 270 | 188 |
Total Liabilities & Shareholders' Equity | 89.5 | 152 | 218 | 300 | 221 |
Total Common Shares Outstanding |